Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reverse Cholesterol Transport in Humans

NCT01603758 is registered in ClinicalTrials.gov with Richard E. Ostlund Jr., MD as lead sponsor.

NCT NCT01603758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01603758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reverse Cholesterol Transport in Humans
Lead sponsor
Richard E. Ostlund Jr., MD
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2014
Completion date
June 30, 2015
Enrollment
132 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, coronary heart disease, disorder of cholesterol metabolism, dyslipidemia